HOME >> MEDICINE >> NEWS
NPSF workshop builds community to improve pharmaceutical safety

Chicago, IL - On June 10-11, 1999, the National Patient Safety Foundation (NPSF) will convene a workshop in Washington, DC to design and build consensus around a collaborative action plan to promote pharmaceutical safety. Fifty opinion leaders will participate, representing five key stakeholder groups that can make a difference - the FDA & Government, Medicine & Health Care Practitioners, Pharmacists, Patients & Public Interest Groups, and the Pharmaceutical Industry.

"Each of these groups is working to assure pharmaceutical safety every day. But until all stakeholders in the pharmaceutical safety chain begin to align our strategies and work collaboratively, our efforts will not reach their full potential to maximize benefit and reduce risk and harm to patients," says Eleanor Vogt, RPh, PhD, Senior Fellow of the NPSF. "This workshop provides a neutral forum to leverage the discussion about underlying issues that keep the community from working together to advance safety."

Expected outcomes of this workshop include a collaborative action plan to be released this summer for a pharmaceutical safety initiative. The plan will incorporate the group consensus on the strengths and vulnerabilities of the system, the roles and responsibilities of the major players in the pharmaceutical chain, the existing tools and resources, and the gaps that need to be filled to responsibly address medication safety issues. It will serve as an action agenda for the work of the community as well as the NPSF.

This project is made possible by a public/private partnership reflected in a major grant from Pfizer Inc with additional support from Bristol-Myers Squibb Research Institute, CVS Drug Stores, DuPont Pharmaceuticals Company, the US Food and Drug Administration, the Warner-Lambert company and Janssen Pharmaceutica.

Founded in 1997 by the American Medical Association, CNA HealthPro, 3M, and other partners, the National Patient Safety Foundation is an independent, nonpro
'"/>

Contact: Susan Wagner
susan_wagner@ama-assn.org
312-464-5418
National Patient Safety Foundation
9-Jun-1999


Page: 1 2

Related medicine news :

1. NIH convenes workshop on menopausal hormone therapy
2. Hands-on cancer biology workshop for journalists
3. AAPS kicks off new century with workshop on bioanalytical methods validation
4. PQRI workshop to address blend uniformity
5. AAPS workshop to explore regulatory approaches to bioavailability, bioequivalence
6. AAPS workshop to examine changes in analytical methods and packaging
7. AAPS workshop to explore pharmaceutical reference standards
8. AAPS presents workshop on macromolecules
9. Exercise therapy builds strength, mobility in MS patients
10. Success of experimental herpes vaccine builds momentum for human clinical trials
11. Privacy rule builds biomedical research bottleneck

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NPSF workshop builds community improve pharmaceutical safety

(Date:11/22/2014)... Dallas, TX (PRWEB) November 22, 2014 ... Society (ICS) as the complaint that the individual ... times for voiding. The report “Nocturia – Pipeline ... therapeutic development for Nocturia, complete with comparative analysis ... mechanism of action (MoA), route of administration (RoA) ...
(Date:11/22/2014)... York, New York (PRWEB) November 22, 2014 ... of power morcellators ( http://www.morcellatorlawsuit2015.com ) in minimally-invasive ... 450 new signatures since the end of October, Bernstein ... had signed the petition as of November 21st, 2014. ... 31st, when 86,042 supporters had signed on to the ...
(Date:11/22/2014)... wide variety and complexity of foods served at holiday ... allergies, an expert warns. "Every person is different ... that it can be really difficult to avoid all ... allergy and clinical immunology at Wake Forest Baptist Medical ... you know you have food allergies, caution should overrule ...
(Date:11/22/2014)... York, New York (PRWEB) November 22, 2014 ... filed on behalf of patients who allegedly developed Type ... forward in the federal multidistrict litigation now underway in ... LLP reports. According to court documents, the litigation will ... 10:00 a.m. The Court has directed Lead Counsel for ...
(Date:11/22/2014)... Hastings and Hastings, a discount accident attorney in ... with the option of leaving an online review using ... and easy to navigate website that has recently been ... allows clients to research the Hastings and Hastings law ... when retaining an attorney. Those who have been injured ...
Breaking Medicine News(10 mins):Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 3Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 4Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 4Health News:'Tis the Season of Challenges for Those With Food Allergies 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 2Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 3
(Date:11/21/2014)... Nov. 21, 2014 Clementia ... Medicines Agency (EMA) has granted Orphan Medicinal ... product candidate, for the treatment of fibrodysplasia ... severely disabling genetic disease characterized by painful, ... and new abnormal bone formation. This process, ...
(Date:11/21/2014)... IRVINE, Calif. , Nov. 20, 2014  Edwards ... leader in the science of heart valves and hemodynamic ... corporate giving in 2014 to support a strong launch ... Heartbeat Matters , and to improve the global communities ... In 2014, Edwards, global corporate giving will exceed $8 ...
(Date:11/21/2014)... /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN ) announced today ... be presenting at the 26 th Annual Piper Jaffray ... New York . The formal presentation is scheduled ... addition, Mr. Krakauer and Jorgen B. Hansen , President ... the day. An audio webcast will be ...
Breaking Medicine Technology:Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3Edwards Lifesciences Increases Charitable Giving In 2014 To Support Launch Of Every Heartbeat Matters 2
Cached News: